CONDYLINE 0.5 %
PODOPHYLLOTOXIN : 0.5 % · DIN 01945149 · SANOFI-AVENTIS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is CONDYLINE?
CONDYLINE 0.5 % contains PODOPHYLLOTOXIN : 0.5 %. It is listed in the Health Canada Drug Product Database under DIN 01945149, held by SANOFI-AVENTIS CANADA INC, supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 25-Aug-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CONDYLINE used for?
CONDYLINE (Podofilox Topical Solution 0.5%) is indicated for the topical treatment of external genital warts (Condylomata acuminata) confined to the penile and vulvar regions.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01945149 |
|---|---|
| Brand name | CONDYLINE |
| Generic / active ingredient | PODOPHYLLOTOXIN : 0.5 % |
| Manufacturer | SANOFI-AVENTIS CANADA INC |
| Strength | 0.5 % |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D06BB04 PODOPHYLLOTOXIN |
| AHFS class | 84:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 25-Aug-2021 |
| Original market date | 1992-12-31 00:00:00 |
How is it stored and handled?
Store at 15-25°C, away from light and heat, in a tightly-closed container.
How is it supplied?
amber glass bottle with plastic child-resistant cap containing 3.5 mL of 0.5% podofilox. Package includes a sealed bag containing thirty cotton-tipped applicators.
What can be used instead?
Other Canadian products sharing ATC code D06BB04 PODOPHYLLOTOXIN. 0 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PODOFILM LIQ 250MG/ML | 250 MG | LIQUID | PALADIN PHARMA INC. | CANCELLED POST MARKET | DIN 00598208 |
| WARTEC | 5 MG | LIQUID | STIEFEL LABORATORIES (IRELAND) LIMITED | CANCELLED POST MARKET | DIN 02074788 |
Who else supplies PODOPHYLLOTOXIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PODOPHYLLOTOXIN appears in 663 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.